Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?
Nachman PH. Nat Rev Nephrol. 2009 May;5(5):254-6
Related Articles:
- BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
- Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
- Review article: Progress of treatment in ANCA-associated vasculitis.
Abstract:
Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. Azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.
Recent Comments